TrialAIDS research and therapy2019

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1: subgroup analyses of the phase 3 EMERALD study.

Gregory D Huhn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.